Table 1: Patient variables.

 

Caucasian

Hispanic

African American

Asian

Other

 

n

2470

431

342

538

18

3799

%

65

11.3

9

14.2

0.5

 

Sex

 

 

 

 

 

 

Female

48%

49%

54%

51%

17%

 

Male

52%

51%

47%

49%

83%

P = 0.114

Age Group

 

 

 

 

 

 

< 50

3%

7%

5%

6%

 

 

50-59

12%

15%

14%

15%

22%

 

60-69

29%

28%

36%

28%

33%

 

70-79

32%

32%

30%

26%

17%

 

> 80

26%

18%

16%

25%

28%

P < 0.001

Mean Age

71.5

68.5

68.8

69.5

69.4

P < 0.001

< 70

59%

67%

68%

62%

72%

 

70 or Greater

41%

33%

32%

38%

28%

P = 0.006

Location

 

 

 

 

 

 

Body

15%

13%

14%

17%

11%

 

Head

48%

49%

47%

47%

44%

 

Tail

15%

16%

14%

13%

11%

 

no

22%

22%

25%

24%

33%

P = 0.904

Tumor Size

 

 

 

 

 

 

Mean Tumor Size (mm)

43.7

44.1

49.3

47

35.2

P = 0.654

n

1749

315

237

382

9

 

Number of Nodes Examined

 

 

 

 

 

 

Mean Number of Nodes

19.02

16.65

20.2

19.1

24.6

P = 0.330

n

436

89

64

96

5

 

Stage

 

 

 

 

 

 

Localized

10%

9%

8%

9%

6%

 

Regional Extension

15%

15%

16%

17%

17%

 

Nodal

25%

24%

24%

26%

22%

 

Distant

53%

53%

52%

52%

44%

 

Unknown

5%

3%

6%

6%

6%

P = 0.953

Treatment

 

 

 

 

 

 

Surgery

16.90%

20.90%

19.30%

17.30%

27.80%

 

Chemotherapy

49.90%

55.20%

53.80%

53.90%

55.60%

 

Radiation

8.10%

10.20%

8.80%

8.20%

11.10%

 

Surgery + Chemo

10.40%

11.10%

9.90%

12.10%

16.70%

 

Surgery + Chemo + XRT

3.10%

4.40%

4.70%

2.80%

11.10%

 

No Treatment

45.50%

38.70%

40.40%

42.20%

44.40%

 

Neoadjuvant Chemo

20.50%

18.60%

20.40%

21.20%

16.70%

P = 0.201